| 000 | 01091 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515071551.0 | ||
| 264 | 0 | _c20070726 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a1479-6694 | ||
| 024 | 7 |
_a10.2217/14796694.3.3.263 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTarhini, Ahmad A | |
| 245 | 0 | 0 |
_aOblimersen in the treatment of metastatic melanoma. _h[electronic resource] |
| 260 |
_bFuture oncology (London, England) _cJun 2007 |
||
| 300 |
_a263-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aThionucleotides _xtherapeutic use |
| 700 | 1 | _aKirkwood, John M | |
| 773 | 0 |
_tFuture oncology (London, England) _gvol. 3 _gno. 3 _gp. 263-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/14796694.3.3.263 _zAvailable from publisher's website |
| 999 |
_c17086873 _d17086873 |
||